JCS Medical, Change of Major Shareholder
JCS Medical announced on the 10th that its largest shareholder is scheduled to change to Syracuse Subco.
Syracuse Subco is a corporation newly established in Korea by Archimed in April, and it announced that from this day until the 22nd of next month, it will conduct a tender offer to purchase 55,724,838 common shares of JCS Medical at 13,000 KRW per share. This corresponds to 72.0% of the total potential issued shares of JCS Medical.
The total amount is approximately 724.4 billion KRW, and NH Investment & Securities is the lead manager for the tender offer.
Hot Picks Today
"Three times Lee Jaeyong's fortune?"... Meet China's richest man, who amassed 134 trillion won at 43.
- "What Happened to Mighty Tesla?"... "Cut Your Exposure," Analysts Warn [Click eStock]
- "I Made an Extra 6 Million Won a Month"... "This Can Actually Make Money?" The Twist Behind a Few Pieces of Junk
- "27,000 Won for an Hour of Walking?"... Robot Dog-Walking Jobs in the U.S. Now Pay by the Hour
- "If You See It, Avoid It"... 'Superfood' Fruit Kills 12-Day-Old Baby
Archimed is a France-based private equity fund management company established in 2014, primarily investing in the healthcare sector including bio-pharmaceuticals, medical technology, and in vitro diagnostics.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
